Literature DB >> 1386357

Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).

T Masaki1, M Matsumoto, I Nakanishi, R Yasuda, T Seya.   

Abstract

Proteolytic inactivation of C4b is a crucial step for regulation of the classical complement pathway. A plasma protease factor I and membrane cofactors, C3b/C4b receptor (CR1) and membrane cofactor protein (MCP), participate in the regulation of cell-bound C4b although the physiological potency of these cofactors remains unknown. We have examined the optimal conditions of the factor I-mediated C4b regulatory system using purified cofactors. CR1 being a cofactor at a cofactor/C4b ratio less than 0.1 (w/w), fluid phase C4b, and methylamine-treated C4 (C4ma) were degraded by factor I into C4bi: minimal Cd4 was generated in the fluid phase. Liposome-bound C4b (LAC4b), on the other hand, was degraded into C4c and C4d. CR1 showed two optimal pHs (6.0 and 7.5) for fluid phase C4b, but one (6.0) for LAC4b, and in both cases low conductivity conditions enhanced the C4bi generation. CR1 cofactor activity was barely influenced by the NP-40 concentration. On the other hand, MCP degraded C4b and C4ma, as a factor I-cofactor, more efficiently into C4c and C4d. Though MCP cofactor activity, like that of CR1, was enhanced under low conductivity conditions, it has only one optimal pH, 6.0, in both fluid and solid phases. Furthermore, as in the case of C3b cleavage, a sufficient NP-40 concentration to solubilize membrane was needed for MCP to express full cofactor activity for C4b, in contrast to CR1. MCP was less potent for C4b inactivation than for C3b inactivation, while CR1 acted as a slightly more effective cofactor for C4b cleavage than for C3b cleavage.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386357     DOI: 10.1093/oxfordjournals.jbchem.a123799

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  14 in total

Review 1.  Protein engineering to target complement evasion in cancer.

Authors:  Darrick Carter; André Lieber
Journal:  FEBS Lett       Date:  2013-11-14       Impact factor: 4.124

2.  Soluble CR1 therapy improves complement regulation in C3 glomerulopathy.

Authors:  Yuzhou Zhang; Carla M Nester; Danniele G Holanda; Henry C Marsh; Russell A Hammond; Lawrence J Thomas; Nicole C Meyer; Lawrence G Hunsicker; Sanjeev Sethi; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2013-08-01       Impact factor: 10.121

3.  Ligation of CD46 to CD40 inhibits CD40 signaling in B cells.

Authors:  Haifa H Jabara; Federica Angelini; Scott R Brodeur; Raif S Geha
Journal:  Int Immunol       Date:  2011-03       Impact factor: 4.823

4.  The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.

Authors:  John B Johnson; Ken Grant; Griffith D Parks
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

5.  Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.

Authors:  Richard J Perrin; Rebecca Craig-Schapiro; James P Malone; Aarti R Shah; Petra Gilmore; Alan E Davis; Catherine M Roe; Elaine R Peskind; Ge Li; Douglas R Galasko; Christopher M Clark; Joseph F Quinn; Jeffrey A Kaye; John C Morris; David M Holtzman; R Reid Townsend; Anne M Fagan
Journal:  PLoS One       Date:  2011-01-12       Impact factor: 3.240

Review 6.  Complement as a regulator of adaptive immunity.

Authors:  Justin Killick; Gregoire Morisse; Dirk Sieger; Anne L Astier
Journal:  Semin Immunopathol       Date:  2017-08-25       Impact factor: 9.623

Review 7.  Rationale for targeting complement in COVID-19.

Authors:  Anastasia Polycarpou; Mark Howard; Conrad A Farrar; Roseanna Greenlaw; Giorgia Fanelli; Russell Wallis; Linda S Klavinskis; Steven Sacks
Journal:  EMBO Mol Med       Date:  2020-07-12       Impact factor: 12.137

8.  Plasma Levels of Complement Factor I and C4b Peptides Are Associated with HIV Suppression.

Authors:  Boyue Wu; Zhengyu Ouyang; Christopher J Lyon; Wei Zhang; Tori Clift; Christopher R Bone; Boan Li; Zhen Zhao; Jason T Kimata; Xu G Yu; Ye Hu
Journal:  ACS Infect Dis       Date:  2017-09-15       Impact factor: 5.084

9.  A teleost CD46 is involved in the regulation of complement activation and pathogen infection.

Authors:  Mo-Fei Li; Zhi-Hai Sui; Li Sun
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

Review 10.  Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.

Authors:  Jack Mellors; Tom Tipton; Stephanie Longet; Miles Carroll
Journal:  Front Immunol       Date:  2020-07-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.